Jane Street Group, LLC Aveo Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.48 - $14.97 $685,811 - $1.21 Million	80,874 New	80,874 $1.21 Million
Q2 2022 Aug 16, 2022	SELL	$3.51 - $6.67 $46,430 - $88,230	-13,228 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$3.15 - $6.01 $60,905 - $116,203	-19,335 Reduced 59.38%	13,228 $74,000
Q2 2021 Aug 16, 2021	SELL	$6.21 - $7.45 $15,239 - $18,282	-2,454 Reduced 7.01%	32,563 $214,000
Q1 2021 May 18, 2021	BUY	$5.97 - $15.28 $209,051 - $535,059	35,017 New	35,017 $256,000
Q4 2020 Feb 17, 2021	SELL	$5.08 - $6.68 $182,432 - $239,892	-35,912 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$4.16 - $6.26 $81,536 - $122,696	19,600 Added 120.16%	35,912 $213,000
Q2 2020 Aug 17, 2020	BUY	$3.47 - $9.99 $56,602 - $162,956	16,312 New	16,312 $84,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.